Back to Search Start Over

Reader Response: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy.

Authors :
Tan BJ
Chan LL
Tan EK
Source :
Neurology [Neurology] 2023 Apr 04; Vol. 100 (14), pp. 688.
Publication Year :
2023

Subjects

Subjects :
Humans
Immunotherapy, Adoptive adverse effects
Cell- and Tissue-Based Therapy
Antigens, CD19
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen therapeutic use
Lymphoma, B-Cell therapy

Details

Language :
English
ISSN :
1526-632X
Volume :
100
Issue :
14
Database :
MEDLINE
Journal :
Neurology
Publication Type :
Academic Journal
Accession number :
37012060
Full Text :
https://doi.org/10.1212/WNL.0000000000207210
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details